News blog

Pacific Biosciences gets sued – and that’s just business as usual

Posted on behalf of Erika Check Hayden Biotechnology lawyers seem unsurprised by a class-action lawsuit filed last month against Pacific Biosciences, the Menlo Park, Calif.-based gene sequencing technology company whose fortunes have declined dramatically over the past year. The suit was filed on 21 December in the US District Court for Northern California on behalf of people and companies who bought stock in PacBio between Oct. 27, 2010 – when the company made its initial public offering – and Sept. 20, 2011. According to the online industry newsletter GenomeWeb, the plaintiff, Thomas J. Primo, alleges that the company made “materially false and misleading 

BACK TO ARTICLE

Tell a Friend

Please ensure that your friend is content to receive an email from us with a link to the article. Select the following link to view our Privacy Policy.

BACK TO ARTICLE